Ambros Therapeutics is a startup based in the United States.
Based in the United States, Ambros Therapeutics is a startup.
Ambros Therapeutics is a clinical-stage biotechnology company developing neridronate, a bisphosphonate drug candidate, to treat Complex Regional Pain Syndrome Type 1 (CRPS-1), a rare and debilitating pain condition.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.